SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001617351-20-000006
Filing Date
2020-01-21
Accepted
2020-01-21 06:40:16
Documents
39
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A lepota10q_amendoct2019.htm 10-Q/A 155956
2 EX 31.1 lepota_ex31z1.htm EX-31.1 7369
3 EX 32.1 lepota_ex32z1.htm EX-32.1 2621
  Complete submission text file 0001617351-20-000006.txt   911720

Data Files

Seq Description Document Type Size
4 none-20191031.xml EX-101.INS 107642
5 none-20191031.xsd EX-101.SCH 14024
6 none-20191031_cal.xml EX-101.CAL 1764
7 none-20191031_def.xml EX-101.DEF 15988
8 none-20191031_lab.xml EX-101.LAB 116596
9 none-20191031_pre.xml EX-101.PRE 66952
Mailing Address 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address 5348 VEGAS DR. LAS VEGAS NV 89108 (7)918-553-9095
LEPOTA INC (Filer) CIK: 0001617351 (see all company filings)

IRS No.: 471549749 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q/A | Act: 34 | File No.: 333-198808 | Film No.: 20535018
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
Office of Trade & Services